|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 158.28 CAD | -1.12% |
|
-6.20% | +25.94% |
| 05-12 | US considers financing billions of dollars for nuclear plant parts, industry group says | RE |
| 05-12 | Canada research roundup-Altius Minerals, Cipher Pharmaceuticals, Suncor Energy | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -0.94 | -0.1 | 1.65 | 2.99 | 3.59 | |||||
Return on Total Capital | -1.2 | -0.13 | 2.05 | 3.82 | 4.66 | |||||
Return On Equity % | -2.09 | 1.67 | 6.05 | 2.76 | 8.89 | |||||
Return on Common Equity | -2.09 | 1.67 | 6.05 | 2.76 | 8.89 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 15.78 | 21.98 | 30.22 | 33.91 | 36.28 | |||||
SG&A Margin | 8.65 | 9.21 | 9.49 | 8.07 | 8.94 | |||||
EBITDA Margin % | 6.54 | 10.22 | 19.43 | 25.17 | 26.17 | |||||
EBITA Margin % | -5.94 | 1.06 | 11.15 | 16.42 | 17.95 | |||||
EBIT Margin % | -7.69 | -0.72 | 9.48 | 15.14 | 16.67 | |||||
Income From Continuing Operations Margin % | -6.96 | 4.78 | 13.94 | 5.48 | 16.93 | |||||
Net Income Margin % | -6.95 | 4.78 | 13.94 | 5.48 | 16.93 | |||||
Net Avail. For Common Margin % | -6.95 | 4.78 | 13.94 | 5.48 | 16.93 | |||||
Normalized Net Income Margin | -3.42 | 2.1 | 11.82 | 5.14 | 14.01 | |||||
Levered Free Cash Flow Margin | 24.84 | -1.71 | 7.03 | 17.64 | 13.78 | |||||
Unlevered Free Cash Flow Margin | 26.54 | -0.15 | 8.32 | 19.47 | 14.77 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.2 | 0.23 | 0.28 | 0.32 | 0.34 | |||||
Fixed Assets Turnover | 0.4 | 0.53 | 0.76 | 0.94 | 1.05 | |||||
Receivables Turnover (Average Receivables) | 6.75 | 8.52 | 8.9 | 8.67 | 10.75 | |||||
Inventory Turnover (Average Inventory) | 1.95 | 2.2 | 2.17 | 2.29 | 2.23 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.18 | 5.92 | 1.55 | 1.62 | 2.47 | |||||
Quick Ratio | 3.9 | 4.45 | 0.83 | 0.8 | 1.51 | |||||
Operating Cash Flow to Current Liabilities | 1.11 | 0.54 | 0.58 | 0.76 | 1.32 | |||||
Days Sales Outstanding (Average Receivables) | 54.08 | 42.86 | 41.01 | 42.21 | 33.96 | |||||
Days Outstanding Inventory (Average Inventory) | 187.26 | 166.24 | 168.19 | 160.16 | 163.33 | |||||
Average Days Payable Outstanding | 65.46 | 47.64 | 63.89 | 19.08 | 25.89 | |||||
Cash Conversion Cycle (Average Days) | 175.87 | 161.46 | 145.31 | 183.3 | 171.41 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 21.01 | 18.71 | 32.27 | 20.36 | 14.67 | |||||
Total Debt / Total Capital | 17.36 | 15.76 | 24.4 | 16.92 | 12.8 | |||||
LT Debt/Equity | 20.95 | 18.62 | 23.99 | 15.82 | 14.61 | |||||
Long-Term Debt / Total Capital | 17.32 | 15.68 | 18.14 | 13.14 | 12.74 | |||||
Total Liabilities / Total Assets | 35.54 | 32.4 | 38.65 | 35.76 | 32.99 | |||||
EBIT / Interest Expense | -2.84 | -0.29 | 4.58 | 5.16 | 10.58 | |||||
EBITDA / Interest Expense | 2.46 | 4.14 | 9.43 | 8.6 | 16.66 | |||||
(EBITDA - Capex) / Interest Expense | -0.01 | 1.06 | 6.56 | 6.3 | 10.59 | |||||
Total Debt / EBITDA | 10.36 | 5.66 | 3.89 | 1.64 | 1.11 | |||||
Net Debt / EBITDA | -3.2 | -6.17 | 2.77 | 0.88 | -0.22 | |||||
Total Debt / (EBITDA - Capex) | -1.97K | 22.06 | 5.59 | 2.23 | 1.74 | |||||
Net Debt / (EBITDA - Capex) | 607.8 | -24.05 | 3.98 | 1.2 | -0.35 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -18.06 | 26.65 | 38.53 | 21.18 | 11.04 | |||||
Gross Profit, 1 Yr. Growth % | -37.12 | 76.47 | 90.42 | 35.97 | 18.82 | |||||
EBITDA, 1 Yr. Growth % | -47.67 | 97.76 | 156.16 | 56.96 | 15.45 | |||||
EBITA, 1 Yr. Growth % | 387.54 | -122.58 | 1.04K | 78.46 | 21.36 | |||||
EBIT, 1 Yr. Growth % | 206.11 | -88.18 | -3.2K | 93.5 | 22.25 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 92.97 | -186.96 | 304.21 | -52.37 | 243.07 | |||||
Net Income, 1 Yr. Growth % | 92.93 | -187.14 | 303.71 | -52.38 | 243.07 | |||||
Normalized Net Income, 1 Yr. Growth % | -2.31K | -177.61 | 617.68 | -47.33 | 202.76 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 93.56 | -184.62 | 277.27 | -53.01 | 246.15 | |||||
Accounts Receivable, 1 Yr. Growth % | 63.21 | -38.13 | 146.76 | -25.19 | 9.32 | |||||
Inventory, 1 Yr. Growth % | -34.42 | 62.94 | 2.31 | 15.52 | 4.22 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -5.17 | -2.88 | -3.01 | -2.44 | 1.17 | |||||
Total Assets, 1 Yr. Growth % | -0.83 | 14.83 | 15.07 | -0.27 | 3.98 | |||||
Tangible Book Value, 1 Yr. Growth % | -2.2 | 20.74 | 4.52 | 4.52 | 8.58 | |||||
Common Equity, 1 Yr. Growth % | -2.27 | 20.43 | 4.42 | 4.43 | 8.47 | |||||
Cash From Operations, 1 Yr. Growth % | 705.58 | -33.53 | 125.91 | 31.56 | 55.58 | |||||
Capital Expenditures, 1 Yr. Growth % | 27.53 | 45.21 | 7.1 | 37.76 | 57.36 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -486.97 | -108.67 | -875.13 | 196.23 | -13.77 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -648.61 | -100.72 | 3.68K | 177.28 | -16.26 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 50 | 0 | 33.33 | 50 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -11.02 | 1.87 | 32.45 | 29.56 | 16 | |||||
Gross Profit, 2 Yr. CAGR % | -41.12 | 5.34 | 83.31 | 60.91 | 27.11 | |||||
EBITDA, 2 Yr. CAGR % | -57.03 | 1.78 | 128.29 | 100.52 | 34.61 | |||||
EBITA, 2 Yr. CAGR % | -41.19 | 4.87 | 81.6 | 351.55 | 47.17 | |||||
EBIT, 2 Yr. CAGR % | -29.36 | -39.85 | 47.05 | 674.41 | 53.81 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 17.83 | 29.54 | 87.48 | 38.75 | 27.82 | |||||
Net Income, 2 Yr. CAGR % | 17.74 | 29.66 | 87.56 | 38.66 | 27.82 | |||||
Normalized Net Income, 2 Yr. CAGR % | -41.75 | 314.01 | 146.14 | 94.43 | 26.28 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 17.93 | 27.98 | 78.67 | 33.14 | 27.53 | |||||
Accounts Receivable, 2 Yr. CAGR % | -8.21 | 0.49 | 23.56 | 35.87 | -9.56 | |||||
Inventory, 2 Yr. CAGR % | 11.48 | 3.37 | 29.11 | 8.72 | 9.73 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -1.96 | -4.03 | -2.95 | -2.73 | -0.65 | |||||
Total Assets, 2 Yr. CAGR % | 0.61 | 6.71 | 14.95 | 7.13 | 1.83 | |||||
Tangible Book Value, 2 Yr. CAGR % | -1.43 | 8.66 | 12.34 | 4.52 | 6.53 | |||||
Common Equity, 2 Yr. CAGR % | -1.5 | 8.49 | 12.14 | 4.43 | 6.43 | |||||
Cash From Operations, 2 Yr. CAGR % | -6.75 | 131.4 | 22.54 | 72.39 | 43.06 | |||||
Capital Expenditures, 2 Yr. CAGR % | 14.6 | 36.08 | 24.71 | 21.46 | 47.23 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -12.45 | -41.86 | -29.83 | 385.57 | 60.32 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -12.93 | -79.99 | -26.09 | 935.54 | 52.81 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 22.47 | 22.47 | 15.47 | 41.42 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -10.99 | 0.09 | 12.86 | 28.58 | 23.07 | |||||
Gross Profit, 3 Yr. CAGR % | -34.71 | -15.11 | 28.32 | 65.94 | 45.44 | |||||
EBITDA, 3 Yr. CAGR % | -46.43 | -28.5 | 39.76 | 101.49 | 66.81 | |||||
EBITA, 3 Yr. CAGR % | -33.94 | -57.27 | 152.3 | 80.55 | 191.41 | |||||
EBIT, 3 Yr. CAGR % | -25.58 | -61.07 | 87.76 | 61.14 | 318.54 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -14.84 | 6.48 | 89.29 | 18.74 | 87.62 | |||||
Net Income, 3 Yr. CAGR % | -14.88 | 6.5 | 89.33 | 18.77 | 87.54 | |||||
Normalized Net Income, 3 Yr. CAGR % | -25.4 | -35.91 | 411.46 | 47.22 | 125.36 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -14.77 | 5.57 | 83.5 | 14.47 | 83.08 | |||||
Accounts Receivable, 3 Yr. CAGR % | -11.64 | -19.52 | 35.57 | 4.53 | 26.37 | |||||
Inventory, 3 Yr. CAGR % | -3.22 | 26.51 | 3.02 | 24.41 | 7.2 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -2.69 | -2.27 | -3.69 | -2.78 | -1.44 | |||||
Total Assets, 3 Yr. CAGR % | -2.13 | 5.14 | 9.43 | 9.64 | 6.07 | |||||
Tangible Book Value, 3 Yr. CAGR % | -0.91 | 5.47 | 7.27 | 9.67 | 5.86 | |||||
Common Equity, 3 Yr. CAGR % | -0.99 | 5.33 | 7.12 | 9.51 | 5.76 | |||||
Cash From Operations, 3 Yr. CAGR % | -11.78 | -16.7 | 129.55 | 25.47 | 66.6 | |||||
Capital Expenditures, 3 Yr. CAGR % | 21.29 | 24.01 | 25.64 | 28.91 | 32.41 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -27.85 | -59.39 | 24.3 | 14.42 | 173.5 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -27.33 | -82.31 | 44.52 | 15.7 | 348.64 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0 | 14.47 | 14.47 | 25.99 | 25.99 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -9.51 | -2.83 | 4.35 | 10.98 | 14.11 | |||||
Gross Profit, 5 Yr. CAGR % | -23.78 | -12.59 | -1.33 | 9.63 | 27.83 | |||||
EBITDA, 5 Yr. CAGR % | -32.44 | -21.2 | -4.32 | 8.62 | 37.68 | |||||
EBITA, 5 Yr. CAGR % | -22.94 | -37.88 | -1.03 | 15.25 | 103.36 | |||||
EBIT, 5 Yr. CAGR % | -17.23 | -40.82 | -2.28 | 15.87 | 73.36 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 11.38 | -15.3 | 16.76 | 18.37 | 61.78 | |||||
Net Income, 5 Yr. CAGR % | 10.73 | -15.29 | 16.75 | 18.35 | 61.8 | |||||
Normalized Net Income, 5 Yr. CAGR % | -19 | -9.79 | 20.26 | 1.6 | 192.3 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.2 | -15.81 | 14.6 | 15.84 | 58.65 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.77 | -15.65 | 1.04 | -0.76 | 15.3 | |||||
Inventory, 5 Yr. CAGR % | -19.1 | -5.64 | 8.61 | 19.07 | 5.65 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -5.14 | -3.69 | -2.8 | -2.45 | -2.49 | |||||
Total Assets, 5 Yr. CAGR % | -1.84 | 2.11 | 4.38 | 5.93 | 6.32 | |||||
Tangible Book Value, 5 Yr. CAGR % | -1.05 | 3.86 | 4.19 | 5.09 | 6.97 | |||||
Common Equity, 5 Yr. CAGR % | -1.62 | 3.73 | 4.07 | 4.97 | 6.84 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.97 | -12.56 | 0.61 | 11.43 | 89.99 | |||||
Capital Expenditures, 5 Yr. CAGR % | -14.56 | 4.7 | 22.65 | 22.99 | 33.87 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 22.85 | -43.03 | -28.53 | 2.96 | 38.35 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 17.06 | -65.47 | -26.73 | 3.42 | 48.44 | |||||
Dividend Per Share, 5 Yr. CAGR % | -27.52 | -21.4 | 8.45 | 14.87 | 24.57 |
- Stock Market
- Equities
- CCO Stock
- Financials Cameco Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















